Free Trial

The Pennant Group (PNTG) Competitors

The Pennant Group logo
$23.35 +0.25 (+1.08%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$23.35 0.00 (0.00%)
As of 07/25/2025 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PNTG vs. SHC, SGRY, CON, PRVA, WGS, VCYT, ARDT, ADUS, PGNY, and PACS

Should you be buying The Pennant Group stock or one of its competitors? The main competitors of The Pennant Group include Sotera Health (SHC), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), GeneDx (WGS), Veracyte (VCYT), Ardent Health (ARDT), Addus HomeCare (ADUS), Progyny (PGNY), and PACS Group (PACS). These companies are all part of the "healthcare" industry.

The Pennant Group vs. Its Competitors

The Pennant Group (NASDAQ:PNTG) and Sotera Health (NASDAQ:SHC) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, risk, valuation and media sentiment.

The Pennant Group has a net margin of 3.40% compared to Sotera Health's net margin of 2.24%. Sotera Health's return on equity of 41.08% beat The Pennant Group's return on equity.

Company Net Margins Return on Equity Return on Assets
The Pennant Group3.40% 10.73% 4.00%
Sotera Health 2.24%41.08%5.68%

In the previous week, Sotera Health had 2 more articles in the media than The Pennant Group. MarketBeat recorded 7 mentions for Sotera Health and 5 mentions for The Pennant Group. Sotera Health's average media sentiment score of 0.76 beat The Pennant Group's score of 0.68 indicating that Sotera Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
The Pennant Group
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
Sotera Health
2 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

The Pennant Group presently has a consensus price target of $33.80, indicating a potential upside of 44.75%. Sotera Health has a consensus price target of $16.00, indicating a potential upside of 30.08%. Given The Pennant Group's higher probable upside, research analysts plainly believe The Pennant Group is more favorable than Sotera Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
The Pennant Group
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.60
Sotera Health
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80

The Pennant Group has a beta of 1.51, suggesting that its stock price is 51% more volatile than the S&P 500. Comparatively, Sotera Health has a beta of 1.81, suggesting that its stock price is 81% more volatile than the S&P 500.

85.9% of The Pennant Group shares are held by institutional investors. Comparatively, 91.0% of Sotera Health shares are held by institutional investors. 5.4% of The Pennant Group shares are held by insiders. Comparatively, 47.5% of Sotera Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Sotera Health has higher revenue and earnings than The Pennant Group. The Pennant Group is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Pennant Group$695.24M1.16$22.56M$0.7630.72
Sotera Health$1.11B3.15$44.34M$0.08153.75

Summary

Sotera Health beats The Pennant Group on 13 of the 16 factors compared between the two stocks.

Get The Pennant Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for PNTG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PNTG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PNTG vs. The Competition

MetricThe Pennant GroupMED IndustryMedical SectorNASDAQ Exchange
Market Cap$796.23M$3.78B$5.69B$9.50B
Dividend YieldN/A1.34%4.58%4.01%
P/E Ratio30.7232.7428.1020.05
Price / Sales1.16123.93432.4490.07
Price / Cash25.0621.9036.2258.56
Price / Book2.574.408.665.87
Net Income$22.56M$189.47M$3.25B$258.55M
7 Day Performance-0.34%2.10%4.23%3.74%
1 Month Performance-19.73%-4.24%10.52%11.75%
1 Year Performance-20.33%-2.92%34.41%18.03%

The Pennant Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PNTG
The Pennant Group
3.6036 of 5 stars
$23.35
+1.1%
$33.80
+44.8%
-20.1%$796.23M$695.24M30.727,000
SHC
Sotera Health
3.073 of 5 stars
$11.61
-1.6%
$16.00
+37.8%
-9.6%$3.30B$1.10B145.143,000News Coverage
Positive News
SGRY
Surgery Partners
2.9703 of 5 stars
$22.47
+2.0%
$33.56
+49.3%
-30.9%$2.88B$3.11B-14.6915,000
CON
Concentra Group Holdings Parent
3.1538 of 5 stars
$20.23
+1.6%
$28.50
+40.9%
N/A$2.59B$1.90B15.0911,250News Coverage
Positive News
PRVA
Privia Health Group
4.1575 of 5 stars
$20.89
+2.1%
$28.38
+35.9%
-1.5%$2.55B$1.80B174.101,140News Coverage
Positive News
WGS
GeneDx
3.9719 of 5 stars
$82.39
-0.2%
$92.33
+12.1%
+144.0%$2.35B$330.14M-58.431,200Upcoming Earnings
VCYT
Veracyte
3.6864 of 5 stars
$26.65
-1.6%
$40.90
+53.5%
+6.3%$2.09B$445.76M65.00790News Coverage
Positive News
Analyst Upgrade
Gap Up
ARDT
Ardent Health
3.5501 of 5 stars
$14.51
+2.4%
$20.67
+42.4%
-34.7%$2.08B$5.97B8.9024,900
ADUS
Addus HomeCare
4.9631 of 5 stars
$111.75
+0.7%
$142.57
+27.6%
-9.7%$2.06B$1.15B25.2349,703Positive News
PGNY
Progyny
1.0866 of 5 stars
$23.47
+1.1%
$24.09
+2.6%
-19.2%$2.01B$1.17B41.18310News Coverage
Positive News
Analyst Upgrade
PACS
PACS Group
2.4646 of 5 stars
$12.93
+1.9%
$34.29
+165.3%
-65.8%$1.97B$3.11B0.0032,433

Related Companies and Tools


This page (NASDAQ:PNTG) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners